ID

18727

Descripción

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00181688

Link

https://clinicaltrials.gov/show/NCT00181688

Palabras clave

Versiones (1)
  1. 17/11/16 17/11/16 -
Subido en

17 de noviembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Ovarian Cancer NCT00181688

Inglés

Eligibility Ovarian Cancer NCT00181688

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic or cytologic history diagnosis of primary ovarian, primary peritoneal or tubal carcinoma
Descripción

Ovarian Carcinoma Primary | Primary peritoneal carcinoma | Fallopian Tube Carcinoma Primary

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0029925
UMLS CUI [1,2]
C0205225
UMLS CUI [2]
C1514428
UMLS CUI [3,1]
C0238122
UMLS CUI [3,2]
C0205225
asymptomatic from ovarian cancer
Descripción

Ovarian Carcinoma Asymptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0029925
UMLS CUI [1,2]
C0231221
evidence of recurrent ovarian, peritoneal or tubal carcinoma
Descripción

Ovarian cancer recurrent Evidence of | Carcinoma of peritoneum Recurrent Evidence of | Recurrent Fallopian Tube Carcinoma Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278689
UMLS CUI [1,2]
C0332120
UMLS CUI [2,1]
C0948303
UMLS CUI [2,2]
C2945760
UMLS CUI [2,3]
C0332120
UMLS CUI [3,1]
C3897738
UMLS CUI [3,2]
C0332120
tumor sample must be positive for er and/or pr
Descripción

Tumor tissue sample Estrogen receptor positive | Tumor tissue sample Progesterone receptor positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0279754
UMLS CUI [2,1]
C0475358
UMLS CUI [2,2]
C0279759
18 years of age or older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of less than or equal to 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
must be able to tolerate oral intake
Descripción

Intake Oral Ability

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512806
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0085732
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known hypersensitivity to iressa or any of the excipients of this product
Descripción

Hypersensitivity Iressa | Hypersensitivity Iressa Excipient

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0919281
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0919281
UMLS CUI [2,3]
C0015237
other coexisting malignancies or malignancies diagnosed within the last 5 years
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital or st. john's wort
Descripción

Phenytoin | Carbamazepine | Barbiturates | Rifampin | Phenobarbital | ST. JOHN'S WORT EXTRACT

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031507
UMLS CUI [2]
C0006949
UMLS CUI [3]
C0004745
UMLS CUI [4]
C0035608
UMLS CUI [5]
C0031412
UMLS CUI [6]
C0813171
treatment with a non-approved or investigational drug within 30 days
Descripción

Drugs, Non-Prescription | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013231
UMLS CUI [2]
C0013230
any unresolved chronic toxicity greater than ctc grad 2 from previous anticancer therapy (except alopecia)
Descripción

Toxicity chronic Unresolved Due to cancer treatment | CTCAE Grades | Alopecia

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0205191
UMLS CUI [1,3]
C0443342
UMLS CUI [1,4]
C0678226
UMLS CUI [1,5]
C0920425
UMLS CUI [2]
C1516728
UMLS CUI [3]
C0002170
incomplete healing from previous oncologic or other major surgery
Descripción

cancer surgery | major surgery | Therapeutic procedure Incomplete

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920424
UMLS CUI [2]
C0679637
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0205257
serum creatinine level greater than ctc grade 2
Descripción

Creatinine measurement, serum | CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1516728
pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
severe uncontrolled systemic disease
Descripción

Systemic disease Uncontrolled Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205082
significant clinical disorder or laboratory finding that makes it potentially unsafe for the subject to participate
Descripción

Disease Significant At risk Study Subject Participation Status | Laboratory finding At risk Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0750502
UMLS CUI [1,3]
C1444641
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C0587081
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C2348568
patients currently receiving other investigational antineoplastic agents, on systemic chemotherapy or under radiation therapy treatment
Descripción

Antineoplastic Agents Investigational | Systemic Chemotherapy | Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003392
UMLS CUI [1,2]
C1517586
UMLS CUI [2]
C1883256
UMLS CUI [3]
C1522449
patients previously treated with anastrozole or other aromatase inhibitor
Descripción

anastrozole | Aromatase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0290883
UMLS CUI [2]
C0593802
unable to tolerate oral medications
Descripción

Oral medication Receive Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
clinical and/or radiographic evidence of current or impending bowel obstruction
Descripción

Intestinal Obstruction Evidence Clinical | Intestinal Obstruction Impending Evidence Clinical | Intestinal Obstruction Evidence roentgenographic | Intestinal Obstruction Impending Evidence roentgenographic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021843
UMLS CUI [1,2]
C3887511
UMLS CUI [1,3]
C0205210
UMLS CUI [2,1]
C0021843
UMLS CUI [2,2]
C0332190
UMLS CUI [2,3]
C3887511
UMLS CUI [2,4]
C0205210
UMLS CUI [3,1]
C0021843
UMLS CUI [3,2]
C3887511
UMLS CUI [3,3]
C0034571
UMLS CUI [4,1]
C0021843
UMLS CUI [4,2]
C0332190
UMLS CUI [4,3]
C3887511
UMLS CUI [4,4]
C0034571
Volver a la parte superior de la página

Similar models

Eligibility Ovarian Cancer NCT00181688

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Ovarian Carcinoma Primary | Primary peritoneal carcinoma | Fallopian Tube Carcinoma Primary
Item
histologic or cytologic history diagnosis of primary ovarian, primary peritoneal or tubal carcinoma
boolean
C0029925 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C1514428 (UMLS CUI [2])
C0238122 (UMLS CUI [3,1])
C0205225 (UMLS CUI [3,2])
Ovarian Carcinoma Asymptomatic
Item
asymptomatic from ovarian cancer
boolean
C0029925 (UMLS CUI [1,1])
C0231221 (UMLS CUI [1,2])
Ovarian cancer recurrent Evidence of | Carcinoma of peritoneum Recurrent Evidence of | Recurrent Fallopian Tube Carcinoma Evidence of
Item
evidence of recurrent ovarian, peritoneal or tubal carcinoma
boolean
C0278689 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0948303 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
C0332120 (UMLS CUI [2,3])
C3897738 (UMLS CUI [3,1])
C0332120 (UMLS CUI [3,2])
Tumor tissue sample Estrogen receptor positive | Tumor tissue sample Progesterone receptor positive
Item
tumor sample must be positive for er and/or pr
boolean
C0475358 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0475358 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of less than or equal to 1
boolean
C1520224 (UMLS CUI [1])
Intake Oral Ability
Item
must be able to tolerate oral intake
boolean
C1512806 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Iressa | Hypersensitivity Iressa Excipient
Item
known hypersensitivity to iressa or any of the excipients of this product
boolean
C0020517 (UMLS CUI [1,1])
C0919281 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0919281 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Malignant Neoplasms
Item
other coexisting malignancies or malignancies diagnosed within the last 5 years
boolean
C0006826 (UMLS CUI [1])
Phenytoin | Carbamazepine | Barbiturates | Rifampin | Phenobarbital | ST. JOHN'S WORT EXTRACT
Item
concomitant use of phenytoin, carbamazepine, barbiturates, rifampicin, phenobarbital or st. john's wort
boolean
C0031507 (UMLS CUI [1])
C0006949 (UMLS CUI [2])
C0004745 (UMLS CUI [3])
C0035608 (UMLS CUI [4])
C0031412 (UMLS CUI [5])
C0813171 (UMLS CUI [6])
Drugs, Non-Prescription | Investigational New Drugs
Item
treatment with a non-approved or investigational drug within 30 days
boolean
C0013231 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Toxicity chronic Unresolved Due to cancer treatment | CTCAE Grades | Alopecia
Item
any unresolved chronic toxicity greater than ctc grad 2 from previous anticancer therapy (except alopecia)
boolean
C0600688 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0443342 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,4])
C0920425 (UMLS CUI [1,5])
C1516728 (UMLS CUI [2])
C0002170 (UMLS CUI [3])
cancer surgery | major surgery | Therapeutic procedure Incomplete
Item
incomplete healing from previous oncologic or other major surgery
boolean
C0920424 (UMLS CUI [1])
C0679637 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0205257 (UMLS CUI [3,2])
Creatinine measurement, serum | CTCAE Grades
Item
serum creatinine level greater than ctc grade 2
boolean
C0201976 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Systemic disease Uncontrolled Severe
Item
severe uncontrolled systemic disease
boolean
C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Disease Significant At risk Study Subject Participation Status | Laboratory finding At risk Study Subject Participation Status
Item
significant clinical disorder or laboratory finding that makes it potentially unsafe for the subject to participate
boolean
C0012634 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C0587081 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
Antineoplastic Agents Investigational | Systemic Chemotherapy | Therapeutic radiology procedure
Item
patients currently receiving other investigational antineoplastic agents, on systemic chemotherapy or under radiation therapy treatment
boolean
C0003392 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C1883256 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
anastrozole | Aromatase Inhibitors
Item
patients previously treated with anastrozole or other aromatase inhibitor
boolean
C0290883 (UMLS CUI [1])
C0593802 (UMLS CUI [2])
Oral medication Receive Unable
Item
unable to tolerate oral medications
boolean
C0175795 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Intestinal Obstruction Evidence Clinical | Intestinal Obstruction Impending Evidence Clinical | Intestinal Obstruction Evidence roentgenographic | Intestinal Obstruction Impending Evidence roentgenographic
Item
clinical and/or radiographic evidence of current or impending bowel obstruction
boolean
C0021843 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0021843 (UMLS CUI [2,1])
C0332190 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C0205210 (UMLS CUI [2,4])
C0021843 (UMLS CUI [3,1])
C3887511 (UMLS CUI [3,2])
C0034571 (UMLS CUI [3,3])
C0021843 (UMLS CUI [4,1])
C0332190 (UMLS CUI [4,2])
C3887511 (UMLS CUI [4,3])
C0034571 (UMLS CUI [4,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial